X0508 4 2025-05-07 0001099800 Edwards Lifesciences Corp EW 0001740963 Chopra Daveen ONE EDWARDS WAY IRVINE CA 92614 1 CVP, TMTT 0 Common Stock 2025-05-07 4 F 0 627.0000 74.9200 D 26376.0000 D Common Stock 2025-05-08 4 A 0 9200.0000 0.0000 A 35576.0000 D Employee Stock Option (Right to Acquire) 74.6300 2025-05-08 4 A 0 47000.0000 0.0000 A 2026-05-08 2032-05-07 Common Stock 47000.0000 47000.0000 D Performance Rights 2025-05-08 4 A 0 9200.0000 0.0000 A 2028-05-08 Common Stock 9200.0000 9200.0000 D These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2025-05-09